Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • New Podcast: Robbery, Inc
  • Federal Funding Update
  • Explore GPB Passport

News Articles: AstraZeneca

A health worker inoculates 72-year-old Olga D'arc Pimentel with a dose of Oxford-AstraZeneca's COVID-19 vaccine. She lives on the banks of the Rio Negro near Manaus, Brazil. A small study in South Africa has raised concerns about the AstraZeneca vaccine's effectiveness.

Tagged as: 

  • Global Health

You Think The U.S. Has Vaccine Issues? 130 Countries Haven't Even Started Vaccinating

For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.

February 14, 2021
|
By:
  • Jason Beaubien
A vial of the AstraZeneca COVID-19 vaccine. A small study in South Africa has raised concerns about its effectiveness, but the World Health Organization has now stated: "Even if there is a possibility that this vaccine has a reduction in efficacy, we see no reason <em>not</em> to use it, even in countries with variants."

Tagged as: 

  • Global Health

Up Against Mutants, WHO Says AstraZeneca Vaccine Is Still A Good Bet

A small study in South Africa has raised concerns about the effectiveness of the AstraZeneca vaccine, particularly in fighting virus variants.

February 11, 2021
|
By:
  • Jason Beaubien
European Commission President Ursula von der Leyen announced AstraZeneca will deliver nine million additional doses of the company's coronavirus vaccine to the EU.

Tagged as: 

  • Europe

EU To Get 9 Million More AstraZeneca Doses After Supply Row

European Commission President Ursula von der Leyen announced Sunday that AstraZeneca would also deliver the vaccines one week earlier than originally scheduled.

February 01, 2021
|
By:
  • Jaclyn Diaz
Stella Kyriakides, European commissioner for health and food safety, said that in the future all companies producing COVID-19 vaccines in the EU "will have to provide early notification whenever they want to export vaccines to third countries."

Tagged as: 

  • Europe

European Union Warns AstraZeneca Over Reduction In Vaccine Shipments

"The companies must deliver. They must honor their obligations," the European Commission's president said after both AstraZeneca and Pfizer said they were experiencing shipping issues.

January 26, 2021
|
By:
  • Jaclyn Diaz and
  • Merrit Kennedy
A health worker gets ready to take samples from people to test for COVID-19 as another registers them at a marketplace last month in New Delhi.

Tagged as: 

  • Asia

India Authorizes AstraZeneca COVID-19 Vaccine For Emergency Use

Almost 150,000 people in India have died from complications of COVID-19, behind only the U.S. and Brazil. India plans to begin inoculating its population of 1.4 billion this month.

January 02, 2021
|
By:
  • Sushmita Pathak
U.K. Prime Minister Boris Johnson looks at the newly authorized AstraZeneca/Oxford University COVID-19 vaccine.

Tagged as: 

  • Health

U.K. Approves AstraZeneca-Oxford Coronavirus Vaccine

The British government has ordered 100 million doses, enough to vaccinate 50 million residents.

December 30, 2020
|
By:
  • Jaclyn Diaz

Tagged as: 

  • Medical Treatments

How Rich Countries Are 'Hoarding' The World's Vaccines, In Charts

Experts say low-risk people in the U.S. will likely be immunized before many high-risk people in poor countries.

December 04, 2020
|
By:
  • Michaeleen Doucleff
The phase 3 trial of Johnson & Johnson's COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant's "unexplained illness."

Tagged as: 

  • Health

Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.

October 13, 2020
|
By:
  • Laurel Wamsley,
  • Richard Harris,
  • and 1 more
Earlier in the week, AstraZeneca had paused worldwide studies of its candidate vaccine after one U.K. participant developed symptoms consistent with the spinal cord inflammation known as transverse myelitis.

Tagged as: 

  • Health

AstraZeneca Resumes Its COVID-19 Vaccine Trials In The U.K.

The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.

September 12, 2020
|
By:
  • Joe Palca
The AstraZeneca/Oxford partnership is one of the vaccine development efforts that is furthest along. The company recently began a Phase 3 trial in the United States that aims to enroll 30,000 volunteers.

Tagged as: 

  • Science

COVID-19 Vaccine Trial Paused Due To Illness In Volunteer

AstraZeneca, which is working with the University of Oxford, hasn't said what the illness is. It will try to determine whether the illness is related to the vaccine, or just a chance event.

September 09, 2020
|
By:
  • Joe Palca

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®